Jacob Asset Management of New York’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$555K Sell
250,084
-3,000
-1% -$8.38K 0.78% 41
2023
Q2
$860K Hold
253,084
0.97% 37
2023
Q1
$1.01M Buy
253,084
+4,000
+2% +$17.6K 1.18% 31
2022
Q4
$1.36M Sell
249,084
-1,860
-0.7% -$10.9K 1.65% 22
2022
Q3
$1.26M Hold
250,944
1.37% 27
2022
Q2
$956K Sell
250,944
-123,282
-33% -$787K 0.97% 30
2022
Q1
$2.65M Buy
+374,226
New +$2.63M 1.61% 22

Other funds holding TGAN

Jacob Asset Management of New York's TGAN Position: Q3 2023 in Review

Jacob Asset Management of New York reduced its Transphorm, Inc. Common Stock (TGAN) stake by 1.2% in Q3 2023, selling an estimated $8.38K and leaving 250,084 shares worth $555K. The position accounts for 0.78% of the portfolio, ranked #41.

Jacob Asset Management of New York first reported a position in TGAN in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.65M in Q1 2022. 39 funds tracked by Wall St. Rank hold TGAN as of Q3 2023.

  • Jacob Asset Management of New York held 250,084 shares of Transphorm, Inc. Common Stock worth $555K as of Q3 2023.
  • Jacob Asset Management of New York sold 3,000 Transphorm, Inc. Common Stock shares in Q3 2023, an estimated $8.38K.
  • Transphorm, Inc. Common Stock made up 0.78% of Jacob Asset Management of New York's portfolio in Q3 2023, its #41 holding.
  • Jacob Asset Management of New York first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and has held it in 7 quarters since.
  • Jacob Asset Management of New York's Transphorm, Inc. Common Stock position peaked at $2.65M in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.